ATAI
Atai BeckleyยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
ATAI Profile
Atai Beckley N.V.
A clinical-stage biopharmaceutical company that developing treatment for mental health disorders
Prof. J.H. Bavincklaan 7, 1183 AT Amstelveen, The Netherlands
--
Atai Beckley N.V. was registered under the laws of the Netherlands on September 10, 2020. On January 11, 2021, it was renamed ATAI Life Sciences B.V. On November 5, 2025, it was renamed Atai Beckley N.V. Atai Beckley N.V. is a clinical-stage biopharmaceutical company dedicated to developing highly effective mental health therapies to improve patient outcomes. The company is advancing the development of a range of product candidates designed to address the complexity of mental health disorders.
